Success Metrics

Clinical Success Rate
100.0%

Based on 16 completed trials

Completion Rate
100%(16/16)
Active Trials
2(9%)
Results Posted
50%(8 trials)

Phase Distribution

Ph phase_3
7
32%
Ph not_applicable
5
23%
Ph phase_2
2
9%
Ph phase_4
3
14%
Ph phase_1
2
9%

Phase Distribution

2

Early Stage

2

Mid Stage

10

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
2(10.5%)
Phase 2Efficacy & side effects
2(10.5%)
Phase 3Large-scale testing
7(36.8%)
Phase 4Post-market surveillance
3(15.8%)
N/ANon-phased studies
5(26.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.1%

16 of 17 finished

Non-Completion Rate

5.9%

1 ended early

Currently Active

2

trials recruiting

Total Trials

22

all time

Status Distribution
Active(3)
Completed(16)
Terminated(1)
Other(2)

Detailed Status

Completed16
unknown2
Recruiting1
Not yet recruiting1
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (10.5%)
Phase 22 (10.5%)
Phase 37 (36.8%)
Phase 43 (15.8%)
N/A5 (26.3%)

Trials by Status

completed1673%
recruiting15%
not_yet_recruiting15%
unknown29%
withdrawn15%
active_not_recruiting15%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT07458022Phase 2

MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER

Active Not Recruiting
NCT05932407

A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression

Completed
NCT03288675Not Applicable

Stepped Care AiTBS 2 Depression Study (Ghent)

Completed
NCT06417437Phase 4

Non-invasive BCI and Application Verification for Depressed People

Recruiting
NCT06337539

Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants

Not Yet Recruiting
NCT05720637Not Applicable

The Efficacy and Cerebral Mechanism of Intradermal Acupuncture for Major Depressive Disorder

Completed
NCT04901494

SSRI's and the Rate of Progression From MCI to Dementia

Withdrawn
NCT05832619Not Applicable

Intradermal Acupuncture Versus Sham Acupuncture and SSRI for Treating Adolescents With Major Depressive Disorder

Unknown
NCT00787501Phase 1

Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression

Completed
NCT01370499Phase 3

A Study of LY2216684 in Participants With Major Depression Disorder

Completed
NCT01903447Phase 4

Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment

Completed
NCT01185340Phase 3

A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Completed
NCT01187407Phase 3

A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Completed
NCT01299272Phase 3

A Study in Prevention of Re-emergence of Depression Symptoms

Completed
NCT01155661Phase 3

A Safety Study in Participants With Major Depressive Disorder

Completed
NCT01173601Phase 3

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Completed
NCT01674361Phase 2

A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)

Completed
NCT02279953Phase 3

Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder

Completed
NCT01751854Phase 1

Enhanced Motor Recovery Using Serotonergic Agents in Stroke

Completed
NCT02262156Not Applicable

CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22